Thryv Therapeutics, Inc.
Clinical trials sponsored by Thryv Therapeutics, Inc., explained in plain language.
-
New heart drug aims to tame deadly rhythm disorder
Disease control Recruiting nowThis study is testing a new drug called THRV-1268 to see if it can safely shorten a dangerous heart rhythm interval in people with Long QT Syndrome Type 2. About 64 participants will take the drug at different doses for several weeks while doctors closely monitor their heart's el…
Phase: PHASE2, PHASE3 • Sponsor: Thryv Therapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Apple tech tracks heart Patients' daily struggles
Knowledge-focused Recruiting nowThis study aims to understand how Long QT Syndrome affects people's daily lives, emotions, and overall well-being. It will enroll up to 200 adults with confirmed LQTS types 2 or 3. Participants will use an iPhone and Apple Watch to answer surveys and track daily health metrics ov…
Sponsor: Thryv Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC